Flexion Therapeutics
| Use attributes for filter ! | |
| Stock price | FLXN |
|---|---|
| Disclaimer | |
| Headquarters | Burlington |
| Massachusetts | |
| United States | |
| Founded | 2007 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2476170 |
About Flexion Therapeutics
Flexion Therapeutics is an American biopharmaceutical company based in Burlington, Massachusetts that is focused on developing and commercializing a sustained release version of triamcinolone acetonide that is intended to be injected into the joint to treat osteoarthritis.
